256 related articles for article (PubMed ID: 26952810)
1. Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Lv W; Chen N; Lin Y; Ma H; Ruan Y; Li Z; Li X; Pan X; Tian X
Cancer Lett; 2016 Jun; 375(2):245-255. PubMed ID: 26952810
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
Yin H; Li X; Gong Q; Jin X; Gu H; Yuan B; Zhang B; Zheng F; Gong F; Zhu J
Mol Immunol; 2010 Sep; 47(15):2443-9. PubMed ID: 20638132
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
Balogh KN; Templeton DJ; Cross JV
PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
[TBL] [Abstract][Full Text] [Related]
4. Ox-LDL induces endothelial cell apoptosis and macrophage migration by regulating caveolin-1 phosphorylation.
Lin F; Pei L; Zhang Q; Han W; Jiang S; Lin Y; Dong B; Cui L; Li M
J Cell Physiol; 2018 Oct; 233(10):6683-6692. PubMed ID: 29323707
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.
Li J; Zhang J; Xie F; Peng J; Wu X
Int J Mol Med; 2018 Feb; 41(2):1062-1068. PubMed ID: 29207023
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor involvement in breast cancer (Review).
Richard V; Kindt N; Saussez S
Int J Oncol; 2015 Nov; 47(5):1627-33. PubMed ID: 26412712
[TBL] [Abstract][Full Text] [Related]
7. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC.
Youn H; Son B; Kim W; Jun SY; Lee JS; Lee JM; Kang C; Kim J; Youn B
J Cell Biochem; 2015 Nov; 116(11):2504-16. PubMed ID: 25900216
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathway.
Zhu J; Luo J; Li Y; Jia M; Wang Y; Huang Y; Ke S
Biochem Biophys Res Commun; 2016 Nov; 480(4):522-527. PubMed ID: 27769864
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor mediates protease-activated receptor 4-induced bladder pain through urothelial high mobility group box 1.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Hunt DE; Leng L; Bucala R; Vera PL
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263120
[TBL] [Abstract][Full Text] [Related]
11. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
[TBL] [Abstract][Full Text] [Related]
12. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
13. Developmental endothelial locus-1 inhibits MIF production through suppression of NF-κB in macrophages.
Lee SH; Kim DY; Kang YY; Kim H; Jang J; Lee MN; Oh GT; Kang SW; Choi EY
Int J Mol Med; 2014 Apr; 33(4):919-24. PubMed ID: 24504014
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells.
Cho ML; Moon YM; Heo YJ; Woo YJ; Ju JH; Park KS; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Mar; 123(1):21-30. PubMed ID: 19428548
[TBL] [Abstract][Full Text] [Related]
17. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Wang Z; Xue Y; Wang P; Zhu J; Ma J
Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity.
Kim MJ; Kim WS; Kim DO; Byun JE; Huy H; Lee SY; Song HY; Park YJ; Kim TD; Yoon SR; Choi EJ; Ha H; Jung H; Choi I
Cell Signal; 2017 Jun; 34():110-120. PubMed ID: 28323005
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
20. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
